Huangqi decoction ameliorates kidney injury in db/db mice by regulating the BMP/Smad signaling pathway
Open Access
- 26 June 2023
- journal article
- research article
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 23 (1) , 1-13
Abstract
Purpose: This study aims to investigate the mechanism underlying the beneficial effects of Huangqi decoction (HQD) on Diabetic kidney disease (DKD) in diabetic db/db mice. Methods: Eight-week-old male diabetic db/db mice were randomly divided into four groups: Model (1% CMC), HQD-L (0.12 g/kg), HQD-M (0.36 g/kg), and HQD-H (1.08 g/kg) groups. Non-diabetic db/m mice were served as the control group. These mice received HQD treatment for 8 weeks. After treatment, the kidney function, histopathology, micro-assay, and protein expression levels were assessed. Results: HQD treatment improved the albumin/creatine ratio (ACR) and 24 h urinary albumin excretion, prevented the pathological phenotypes of increased glomerular volume, widened mesangial areas, the of mesangial matrix proliferation, foot process effacement, decreased nephrin expression and reduced number of podocytes. Expression profiling analysis revealed global transcriptional changes that predicted related functions, diseases and pathways. HQD treatment activated protein expressions of BMP2, BMP7, BMPR2, and active-Rap1, while inhibiting Smad1 and phospho-ERK. In addition, HQD was associated with improvements in lipid deposition in the kidneys of db/db mice. Conclusion: HQD ameliorated the progression of DKD in db/db mice by regulating BMP transcription and downstream targets, inhibiting the phosphorylation of ERK and the expression of Smad1, promoting Rap1 binding to GTP, and regulating the lipid metabolism. These findings provide a potential therapeutic approach for treating DKD.Keywords
This publication has 43 references indexed in Scilit:
- Podocyte-specific RAP1GAP expression contributes to focal segmental glomerulosclerosis–associated glomerular injuryJournal of Clinical Investigation, 2014
- Disruption of Smad4 impairs TGF-β/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitroKidney International, 2012
- TGF-β and BMP Signaling in Osteoblast Differentiation and Bone FormationInternational Journal of Biological Sciences, 2012
- Recent insights into diabetic renal injury from thedb/dbmouse model of type 2 diabetic nephropathyAmerican Journal of Physiology-Renal Physiology, 2011
- Smad-Dependent and Smad-Independent Induction of Id1 by Prostacyclin Analogues Inhibits Proliferation of Pulmonary Artery Smooth Muscle Cells In Vitro and In VivoCirculation Research, 2010
- New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditureNature, 2008
- SIX2 and BMP4 Mutations Associate With Anomalous Kidney DevelopmentJournal of the American Society of Nephrology, 2008
- Bmp in Podocytes Is Essential for Normal Glomerular Capillary FormationJournal of the American Society of Nephrology, 2008
- Renal Bone Morphogenetic Protein-7 Protects against Diabetic NephropathyJournal of the American Society of Nephrology, 2006
- Differential Roles of Smad1 and p38 Kinase in Regulation of Peroxisome Proliferator-activating Receptor γ during Bone Morphogenetic Protein 2-induced AdipogenesisMolecular Biology of the Cell, 2003